Spectral Medical (TSX:EDT) Other Net Income (Loss) : C$-0.11 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical Other Net Income (Loss)?

Spectral Medical's Other Net Income (Loss) for the three months ended in Mar. 2024 was C$-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.11 Mil.

Spectral Medical's quarterly Other Net Income (Loss) increased from Sep. 2023 (C$-0.13 Mil) to Dec. 2023 (C$-0.03 Mil) and increased from Dec. 2023 (C$-0.03 Mil) to Mar. 2024 (C$-0.00 Mil).

Spectral Medical's annual Other Net Income (Loss) declined from Dec. 2021 (C$-2.09 Mil) to Dec. 2022 (C$-3.65 Mil) but then increased from Dec. 2022 (C$-3.65 Mil) to Dec. 2023 (C$-0.16 Mil).

Spectral Medical Other Net Income (Loss) Historical Data

The historical data trend for Spectral Medical's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Other Net Income (Loss) Chart

Spectral Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

-2.09

-3.65

-0.16

Spectral Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-0.04	0.05	-0.13	-0.03	-

Spectral Medical Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.11 Mil.

Spectral Medical Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Spectral Medical (TSX:EDT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

EDTXF:USA SD4:Germany

Address

135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2

Website

https://www.spectraldx.com

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.

Executives

Anthony Phillip Bihl	Director
William Charles Stevens	Director